Adherence to Oral Oncolytics
Best Practices for Supporting Patients on Oral Cancer Therapies
CE PANEL VIDEO
As the use of oral oncolytics increases, cancer programs face a number of challenges to ensure high-quality care for their patients. In this video, a panel of leading experts in oncology practice discuss the key issues involved in patient adherence to oral therapeutics, including awareness, education and communication.
Kimberly M. Hicks, PharmD, MHA (Moderator)
Director of Pharmacy Services at HHCS Health Group of Companies, Orlando, Florida
John Novak, CHA, PA-C
Physician Assistant at Rocky Mountain Cancer Centers, and clinical preceptor at University of Colorado School of Medicine, Aurora, Colorado
Susan Scherer, RN, BSN, OCN
CEO and founder of RN Cancer Guides Solutions in Tampa, Florida
Diane Cope, PhD, ARNP, BC, AOCNP
Oncology nurse practitioner at Florida Cancer Specialists and Research Institute, Ft. Myers, Florida
Access SupplementTHE ROLE OF THE ADVANCED PRACTITIONER IN MAINTAINING ADHERENCE IN PATIENTS ON ORAL ONCOLYTICS
Based on the panel discussion, this supplement to JADPRO centers on the role of the advanced practitioner in maintaining adherence in patients on oral oncolytics. Case studies illustrate common challenges to non-adherence, and steps to successful implementation of oral oncolytics are reviewed.
Download TableTABLE OF ORAL AGENTS USED IN THE TREATMENT OF CANCER
As the number of available oral oncolytics increases rapidly, it becomes more and more important for advanced practitioners to stay current on the medications their patients may be prescribed. This table of over 80 oral agents provides a starting point for keeping up with new approvals.
This CME/CE/CPE accredited activity is jointly provided by